From Our Partners
Tuesday, June 28, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

Biothreat Antibiotic Susceptibility Testing with Biomerieux’s EasyMag

by Global Biodefense Staff
July 31, 2013

The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick has issued a solicitation for Antibiotic Susceptibility Strips and EasyMag System Reagents that determine the quantitative antibiotic susceptibility of biothreat agents.

Previously established USAMRIID protocols require bacterium be grown on agar plates in the presence of antibiotic e-strips coated with antibiotic gradients and marked with quantitative tick marks for measuring the zone of clearing.  This requirement is for brand name or equal EasyMag system reagents, consumables, controls, calibrators, and parts on an as-needed basis. 

“The Biomerieux EasyMag is an automated nucleic acid extraction platform used by our division,” states the announcement. “The system is integrated into an ongoing funded study for both platform evaluation and support of mission essential sample processing.”

The following are the Minimal Essential Characteristics for the EasyMag sample prep reagents to be procured:

  • Must be Biomerieux brand name or equivalent
  • Must be available for all 44 antibiotics requested
  • Must be packaged in 30 strip per package format
  • Must contain clearly labeled gradient tick marks of antibiotic concentration
  • Must provide 15 dilutions per strip
  • Must have antibiotic abbreviation written on top of Estrip
  • Must have expiration date no less than 1.5 years from time of order 

Under the contract, USAMRIID places an order as required, and the vendor delivers as early as the next business day but no later than 5 business days. The Period of Performance is a twelve-month base year with four twelve-month options years. 

Source: FBO.gov

Editor’s Note: While the acquisition of laboratory equipment or reagents is commonplace, we periodically cover these activities for insight into the research, acquisition and mission priorities of biodefense-relevant organizations.

From Our Partners
Tags: AntimicrobialsUSAMRIID

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
NIAID Funding Available for Biocontainment Facility Improvements
Biosecurity

NIAID Funding Available for Biocontainment Facility Improvements

April 8, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC